Please login to the form below
Article 50
This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.
No deal or revoke looming as fourth vote on Brexit nears
So weeks after the EU agreed an extension of Article 50 to 31 October – now just over 160 days away – there seems to have been little progress, despite appeals by President ... Number 10 had been informally saying that if the deals doesn’t get
Latest news
-
UK heart deaths rise for first time in 50 years
50 years, warns a new report from charity the British Heart Foundation.
-
Brexit "having impact on EU drug development”
There’s little sign that the Brexit pressure will let up for a few months at least, now that a delay to the Article 50 date has been set to 31
-
No-deal risk recedes, but new Brexit delay adds to uncertainty
With the extension of Article 50, we will work with Government to consider how best to prepare and review whether current plans for a no deal Brexit are still appropriate.”.
-
Pharma asked to consider 5 things as no-deal Brexit looms again
If ‘no-deal’ were rejected, Article 50 would be revoked and an inquiry set up to establish whether any form of Brexit could command a majority.
-
UK business: Brexit deadlock causing “frustration and anger”
B ‘managed no-deal’ option with an extended transition period; accepting a no-deal exit on 12 April; revoking Article 50 and halting Brexit; and Common Market 2.0 – also known ... When it comes to any further extension to Article 50, which would be
More from news
Approximately 0 fully matching, plus 34 partially matching documents found.
Latest Intelligence
-
Leave or remain? Winning the employee referendum
killer question: ‘Should I stay or should I go?’ Our decision to trigger the employee equivalent of Article 50 will normally be influenced by our experiences with our current employer. ... We all know you. can’t run a business on 50% turnover, but
-
The Patient Safety Challenge
The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme
-
Macron, Merkel and May: implications of the 2017 elections for the life science industry
50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’ transition period
-
Brexit: the facts (and the alternative facts)
How Brexit affects pharma. The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.
-
Brexit: Implications for the pharma industry
Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report
The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.
-
50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need. ... That's why we have created this 50-question checklist to help you deliver an exceptional brand
-
Random42 Named in Alantra’s Pharma Fast 50.
The London based scientific communication studio have been named in this year’s Pharma Fast 50, an annual ranking of the UK’s fastest-growing companies within the pharmaceutical industry. ... For more on the Pharma Fast 50 read the full article: .
-
Research Partnership has been ranked in the Pharma Times Pharma Fast 50
Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research Partnership
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- 20 for 2020 – Five pharma companies to watch
- Leadership change within Bedrock Group
- Moderna inks R&D agreements with Vertex and Chiesi
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
